Guillaume Marie Jean Rutten - 15 Feb 2023 Form 4 Insider Report for AMKOR TECHNOLOGY, INC. (AMKR)

Signature
Mark N. Rogers, Attorney-in-Fact for Guillaume Marie Jean Rutten
Issuer symbol
AMKR
Transactions as of
15 Feb 2023
Net transactions value
-$620,000
Form type
4
Filing time
17 Feb 2023, 16:07:19 UTC
Previous filing
19 Jan 2023
Next filing
17 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMKR Common Stock Options Exercise $47,400 +5,000 +3.2% $9.48 160,000 15 Feb 2023 Direct
transaction AMKR Common Stock Options Exercise $141,700 +10,000 +6.2% $14.17 170,000 15 Feb 2023 Direct
transaction AMKR Common Stock Sale $809,100 -30,000 -18% $26.97 140,000 15 Feb 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMKR Employee Stock Option (Right-to-Buy) Options Exercise $0 -5,000 -20% $0.000000 20,625 15 Feb 2023 Common Stock 5,000 $9.48 Direct F3
transaction AMKR Employee Stock Option (Right-to-Buy) Options Exercise $0 -10,000 -7.5% $0.000000 122,500 15 Feb 2023 Common Stock 10,000 $14.17 Direct F4
transaction AMKR Restricted Stock Units Award $0 +55,679 $0.000000 55,679 16 Feb 2023 Common Stock 55,679 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.64 to $27.25. The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 This stock option (the "2019 Option") to acquire 150,000 shares of the Issuer's common stock (the "2019 Option Shares") was granted on February 15, 2019 (the "2019 Option Grant Date") and vested over four years as follows: (i) with respect to 25% of the 2019 Option Shares, on the first anniversary of the 2019 Option Grant Date; and (ii) with respect to the remainder of the 2019 Option Shares, in equal quarterly installments thereafter, such that 100% of the 2019 Option vested on the fourth anniversary of the 2019 Option Grant Date.
F4 This stock option (the "2020 Option") to acquire 375,000 shares of the Issuer's common stock was granted on July 30, 2020 (the "2020 Option Grant Date") and will vest in equal quarterly installments over three years, such that 100% of the 2020 Option will be vested on the third anniversary of the 2020 Option Grant Date.
F5 Represents shares of the Issuer's common stock underlying time-vested restricted stock units granted on February 16, 2023 (the "RSU Grant Date") pursuant to the Issuer's 2021 Equity Incentive Plan (the "RSUs"). The RSUs were awarded for no consideration other than the Reporting Person's service as an officer of the Issuer and will vest in four equal annual installments beginning on the first anniversary of the RSU Grant Date.